Russell Investments Group
AFIB icon

Russell Investments Group’s Acutus Medical Inc AFIB Stock Holding History

Russell Investments Group’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,304
Closed -$43K – 3320
2021
Q1 		$43K Buy
+3,304
New +$74.4K ﹤0.01% 3042

Other funds holding AFIB

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM

Russell Investments Group's AFIB Position: Q2 2021 in Review

Russell Investments Group sold out of Acutus Medical Inc (AFIB) in Q2 2021, closing a stake of 3,304 shares — an estimated $43K sold.

Russell Investments Group first reported a position in AFIB in Q1 2021 and held it in 1 quarter. The position peaked at $43K in Q1 2021. 64 funds tracked by Wall St. Rank hold AFIB as of Q2 2021.

  • Russell Investments Group reported no remaining Acutus Medical Inc position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 3,304 Acutus Medical Inc shares in Q2 2021, an estimated $43K.
  • Russell Investments Group first reported a position in Acutus Medical Inc in Q1 2021 and held it in 1 quarter.
  • Russell Investments Group's Acutus Medical Inc position peaked at $43K in Q1 2021.
  • 64 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.